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Abstract
Background: The development of novel fertilization treatments, including in vitro fertilization and intracytoplasmic
injection, has made pregnancy possible regardless of the level of activity of the spermatozoa; however, the etiology of male-
factor infertility is poorly understood. Multiple studies, primarily through the use of transgenic animals, have contributed to
a list of candidate genes that may affect male infertility in humans. We examined single nucleotide polymorphisms (SNPs) as
a cause of male infertility in an analysis of spermatogenesis-specific genes.
Methods and Finding: We carried out the prevalence of SNPs in the coding region of phosphoglycerate mutase 4 (PGAM4)
on the X chromosome by the direct sequencing of PCR-amplified DNA from male patients. Using RT-PCR and western blot
analyses, we identified that PGAM4 is a functional retrogene that is expressed predominantly in the testes and is associated
with male infertility. PGAM4 is expressed in post-meiotic stages, including spermatids and spermatozoa in the testes, and
the principal piece of the flagellum and acrosome in ejaculated spermatozoa. A case-control study revealed that 4.5% of
infertile patients carry the G75C polymorphism, which causes an amino acid substitution in the encoded protein.
Furthermore, an assay for enzymatic activity demonstrated that this polymorphism decreases the enzyme’s activity both in
vitro and in vivo.
Conclusion: These results suggest that PGAM4, an X-linked retrogene, is a fundamental gene in human male reproduction
and may escape meiotic sex chromosome inactivation. These findings provide fresh insight into elucidating the mechanisms
of male infertility.
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Introduction
Although at least 40% of cases of human infertility have no
obvious underlying cause, male factors account for approximately
30–40% [1]. Recent studies have revealed that genetic abnormal-
ities might affect the function or expression of important proteins
and thereby affect male fertility adversely [2,3,4]. Spermatogenesis
and fertilization are highly complex processes that involve multiple
genes, not all of which have yet been identified. Therefore, it is
important both to search for genes that are associated with
infertility and to identify genetic risk factors for male infertility.
Retrotransposition can create both pseudogenes and functional
retrogenes by integration of parental mRNA into the genome by
reverse transcriptase. This phenomenon can drive novel functions
and phenotypes and is also associated with the evolutionary
emergence of new species [5]. Retrogenes are transmitted to the
next generation only when retrotransposition occurs in a germline
cell (although retrotransposition can occur in all cell types).
Therefore, retrogenes tend to be expressed in spermatogenic cells
in male mammals [6]. Specifically, the mouse genes encoding the
spermatogenic cell-specific glycolytic enzyme phosphoglycerate
kinase (PGK) 2 (Pgk2) –which is conserved in humans–[7,8] and
aldolase 1 A retrogenes 1 and 2 (Aldoart1 and Aldoart2) [9] were
created by retrotransposition. These genes are expressed at meiotic
or postmeiotic stages and play an essential role in both sperm
motility and male infertility in mice.
We hypothesized that PGAM4 on the X chromosome might be
a functional retrogene expressed in spermatogenic cells that could
affect male fertility by producing phosphoglycerate mutase
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e35195(PGAM)-4 [10,11,12]. PGAM4 was first described as a pseudogene
transposed from PGAM1, retaining 97.6% of its identity [13].
PGAM proteins function downstream of PGK in the glycolytic
pathway, catalyzing the conversion of 3-phosphoglycerate (3-PGA)
to 2-PGA. PGAM4 has high identity of putative amino acid with
PGAM1 and contains the LxRHGExxxN motif for PGAM
enzymatic activity (Fig. S1) [14]. Currently, PGAM4 is believed
to be a functional retrogene because of its neutral theoretical Ka/
Ks ratio and the retention of the enzyme active site. Because it is
only present in chimpanzees, macaques and humans, PGAM4 is
estimated to have arisen at least 25 million years ago [15].
However, the function and localization of the PGAM4 protein are
poorly understood.
Here, we first analyzed complete PGAM4 and PGAM1 cDNA
sequences and found 14 base pair changes, but no insertions,
deletions, or nonsense mutations within the ORF. In addition, as
described [16], PGAM4 contains several TATA boxes and CAAT
boxes upstream from the transcription start site. Moreover, the
TGACCTCA sequence at –822 bp is strikingly homologous to the
cAMP response element consensus sequence, which has a signif-
icant impact on spermatogenesis [17]. Although the PGAM1
promoter sequence contains CpG islands, the promoter sequence
of PGAM4 lacks them. This result is intriguing, as PGK1–which
contains CpG islands–is expressed ubiquitously, whereas PGK2
(which does not) is expressed selectively in spermatogenic cells
[18]. These findings strongly support our hypothesis. We describe
here the specific expression of PGAM4 in postmeiotic stages of
human spermatogenesis and its localization in the principal piece
of the flagellum and in the acrosome in ejaculated spermatozoa. In
addition, a single nucleotide polymorphism (SNP) causing an
amino acid substitution was common in infertile human men and
was shown to reduce the enzyme’s activity. These results indicate
that PGAM4, located on the X chromosome, is a functional
retrogene that is associated with male infertility.
Results
Gene Expression of PGAM1 and PGAM4
To determine whether PGAM4 mRNA is present in the testes
(and specifically in spermatozoa), we performed RT–PCR
amplification using total RNA from human testes (Fig. 1A) and
conventional PCR on samples from a testis-specific cDNA library
(Fig. S2A). Nested PCR using two primer sets specific for PGAM4
was required to amplify PGAM4 selectively (but not PGAM1)
because of the strong identity between the PGAM1 and PGAM4
sequences. The amplified fragments were then digested with
BstXI (Fig. S2B), which cuts only PGAM4. The identities of the
amplified fragments were confirmed by sequencing. A 380-bp
amplicon of PGAM4 was amplified by RT–PCR from testes and
spermatozoa and by PCR from the cDNA library. The PCR
products that were amplified from each source were digested into
239-bp and 181-bp fragments using BstXI. The sequences of the
amplified products perfectly matched the sequence of PGAM4.
Although some reports have suggested that PGAM4 is a pseudo-
gene that is selectively transcribed in leukocytes [13,15], our
results show that it is transcribed in testes and its mRNA is
present in spermatozoa.
Before investigating the localization of PGAM4 in cultured cells,
we performed immunofluorescence and western blot analyses
using transfected COS7 cells that expressed the PGAM1 and
PGAM4 proteins. We first determined the efficacy of an anti-
PGAM1/4 antibody adsorbed with recombinant PGAM4 (sc-
67756; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA)
and a PGAM4-specific antibody (Peptide Institute, Osaka, Japan).
PGAM1 proteins are presumably expressed ubiquitously in
eukaryotic cells, including COS7 cells. Western blot analysis
showed that the anti-PGAM1/4 antibody adsorbed with PGAM4
detected PGAM1 proteins of approximately 29 kDa in size in all
COS7 samples (Fig. 1B). Similarly, immunofluorescence revealed
that PGAM1 (but not PGAM4) could be detected in the cytoplasm
using the anti-PGAM1/4 antibody adsorbed with PGAM4
(Fig. 1C). This result confirmed that the anti-PGAM1/4 antibody
adsorbed with PGAM4 could detect PGAM1, but not PGAM4. In
addition, the PGAM4-specific antibody detected only PGAM4, as
shown by the results of both western blotting (Fig. 1B) and
immunofluorescence analyses (Fig. 1C). Therefore, we used the
anti-PGAM1/4 antibody adsorbed with recombinant PGAM4 as
a PGAM1-specific antibody.
Subcellular Localization of PGAM1 and PGAM4
Next, the PGAM1- and PGAM4-specific antibodies were used
to measure the developmental expression and localization of
PGAM1 and PGAM4 in testes and spermatozoa. The PGAM1-
specific antibody bound to a 29-kDa protein in both leukocytes
and testes, but not in spermatozoa. In contrast, the PGAM4-
specific antibody yielded protein signals in testis and spermatozoa
(Fig. 2A). In testicular sections that had been subjected to
immunofluorescence staining using the PGAM1-specific antibody,
PGAM1 was found to localize to Leydig cells, Sertoli cells and
spermatogenic cells prior to the meiotic divisions including
spermatogonia and spermatocytes (Fig. 2B). In contrast, no
staining was detected in ejaculated spermatozoa, consistent with
the results of our western blot analysis (Fig. 2C). Observing the
morphology of cells stained with PGAM4-specific antibodies
under epifluorescence and DIC microscopes at high magnification
revealed that expression of PGAM4 in the testes was restricted to
postmeiotic spermatogenic cells, especially from spermatids on and
after stage 3 (Fig. 2D and F). In ejaculated spermatozoa, PGAM4
was located in the principal piece of the flagellum and in the
acrosomal region of the spermatozoon head (Fig. 2E).
Detection of SNPs
We investigated whether there might be any PGAM4 genetic
variants affecting male fertility by performing a case-control
study of fertile and infertile men. Genomic DNA was extracted
from either blood or semen and the coding region of the
PGAM4 gene was amplified and sequenced. The analysis
revealed three SNPs, two of which caused missense substitutions
in the protein (Table 1). The third SNP was silent and was only
weakly correlated with fertility status. Among the subjects with
missense substitution-causing SNPs, 17 infertile men had
a guanine-to-cytosine substitution at position 75 (G75C; the
translation start site was at +1). Three fertile men also carried
this SNP. Whereas one infertile man had a guanine-to-adenine
substitution at position 539, none of the fertile men carried this
SNP. Only the incidence of the G75C SNP was significantly
different between the two groups. Therefore, we conclude that
the G75C SNP, resulting in replacement of the tryptophan
residue at position 25 in the protein with a cysteine residue
(Trp25Cys), is associated with infertility.
Enzymatic Activity of PGAM1 and PGAM4
We next compared the enzymatic activities of PGAM4 and
PGAM1 and analyzed the effect of the Trp25Cys substitution
identified in our case-control analysis. We transfected COS7
cells with a pcDNA3.1+ vector carrying a cDNA encoding
PGAM1, PGAM4,o rPGAM4 with the Trp25Cys substitution to
express the full-length proteins. The enzymatic activity of each
A PGAM4 SNP Affects Male Fertility
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enzyme assay for converting 3-PGA to PEP reacts in both time-
and concentration-dependent manners [19]. Because COS7 cells
express endogenous PGAM1, this activity was measured in
control groups that included untransfected COS7 cells and cells
transfected with an empty pcDNA3.1+ vector to determine the
baseline enzymatic activity. Compared with the control group,
the PGAM1 activity in the transfected cells increased signifi-
cantly (4.82 fold). Moreover, PGAM4 activity increased 1.80
fold. Despite being lower than the increase observed for
PGAM1, the increase in PGAM4 activity was statistically
significant (Fig. 3A). Analysis of the effect of the Trp25Cys
substitution on PGAM4 activity revealed that the G75C
substitution caused a significant 26.6% decrease in enzymatic
activity compared with the wild-type PGAM4. In fact, the
mutation reduced the activity of the mutant PGAM4 protein, as
cells that were transfected with Trp25Cys PGAM4 had
enzymatic activity similar to the control cells (Fig. 3B). We
next used an in vivo assay to measure PGAM enzymatic activity
in ejaculated spermatozoa. To evaluate this activity and the
Figure 1. Gene expression analysis of PGAM1 and PGAM4. (A) PGAM4 mRNA detection in human leukocytes, testes and ejaculated
spermatozoa. Total RNA samples from leukocytes, testes and spermatozoa were subjected to RT–PCR analysis. RT–PCR without reverse transcriptase
confirmed the absence of DNA contamination after DNase treatment. M, 100-bp ladder DNA marker. (B) Western blot analysis of transfected COS7 cell
lysates to determine the specificity of the anti-PGAM1 and anti-PGAM4 antibodies for each antigen. Approximately 8 mg of protein from the
transfected cell lysate was loaded. COS7 and pcDNA3.1+ indicate proteins from untransfected cells and cells that were transfected with the empty
pcDNA3.1+ vector, respectively. (C) Immunofluorescence analysis of COS7 cells engineered to overexpress PGAM1 or PGAM4. pcDNA3.1+ indicates
cells that were transfected with pcDNA3.1+ as a negative control. The nuclei were counterstained with DAPI (blue). PGAM1 Ab, PGAM1-specific
antibody; PGAM4 Ab, PGAM4-specific antibody.
doi:10.1371/journal.pone.0035195.g001
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fresh semen obtained from a fertile man were separated into
two fractions based on hydrophilicity [20,21]. Only the
hydrophilic sperm protein fraction exhibited PGAM enzymatic
activity (0.62 U/mg protein) (Fig. 3C). We finally compared
PGAM activity in spermatozoa from men carrying the G75C
SNP and samples from men not carrying the SNP. Three
frozen semen samples carrying the SNP were analyzed. The
average PGAM activity in the samples from three randomly
selected infertile men without the SNP was 0.309 U/mg
protein. In contrast, the enzymatic activities in samples from
three patients with the SNP were 0.067, 0.125 and 0.153 U/mg
protein. This reduced enzymatic activity suggests that the G75C
SNP impairs the metabolic capacity of spermatozoa (Fig. 3D).
Figure 2. Gene expression and localization of PGAM1 and PGAM4. (A) Western blot analysis of total protein from leukocytes, testes,
spermatozoa and transfected cell lysates. Mouse brain lysate was loaded as a positive control for PGAM1. (B–F) Immunohistochemical observations.
Immunofluorescence in the testis was measured using the anti-PGAM1 (B) and anti-PGAM4 (D, F) antibodies. (F) High-power field of D.
Immunofluorescence in the spermatozoa was measured using the anti-PGAM1 (C) and anti-PGAM4 (E) antibodies. PGAM4 protein was detected
postmeiosis in spermatids and spermatozoa (white arrowhead) and was localized to the principal piece (white arrow) and acrosome (white
arrowhead) in ejaculated spermatozoa. Stars indicate nonspecific fluorescence signals from the secondary antibody in interstitial Leydig cells, because
negative control experiments without primary antibodies showed the signals in the interstitial area (data not shown). White bars=20 mm; red
bars=10 mm.
doi:10.1371/journal.pone.0035195.g002
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There are two methods of gene duplication: segmental
duplication and retrotransposition. The former generates daughter
copies that have almost identical sequences and similar expression
patterns through intra- or interchromosomal transposition,
whereas the latter is caused by retrotranscription and integration
of mRNA, which simultaneously creates new genes lacking introns
or pseudogenes. Previously, retrotransposition was thought to
generate nonfunctional genes because it often causes deletion of
ORFs and regulatory elements [22]. Retroposition has been
shown to generate many more functional retrogenes in the primate
lineage leading to humans than had been expected, with the
largest burst of retrotransposition having occurred approximately
38–50 million years ago [5]. The retrotransposed gene PGAM4
was believed, but not proven, to be a functional gene. Dierick et al.
[13] performed RT–PCR using systemic tissues. Only PGAM1
and not PGAM4 was detected systemically–including in the testis–
perhaps because the researchers used primer sets specific for both
PGAM1 and PGAM4. We also performed RT–PCR with testis
RNA and PCR analysis of a testis cDNA library using primer sets
specific for both PGAM1 and PGAM4, but no amplification of
PGAM4 occurred. We speculate that the expression level of
PGAM4 is much lower than that of PGAM1 and that nested PCR
using specific primer sets should therefore be performed to
distinguish the two enzyme expression levels. Many young
retrogenes not found in mice have been reported as tending to
be transcribed at low levels in the testis [23]. This rule can be
applied to the expression pattern of PGAM4 because this variant is
assumed to have arisen approximately 25 million years ago. The
primary role of glycolytic enzymes in the sperm principal piece is
to supply some of the ATP used in sperm motility [24,25]. Despite
normal spermatogenesis, sperm motility was reduced and fully
ablated in Gapds and Pgk2 knockout mice, respectively [8,26]. In
the present study, we showed that the nonsynonymous SNP G75C
caused a significant decrease in PGAM4 enzymatic activity. We
propose that PGAM4 contributes to reduced sperm motility, and
thus infertility, by impairing glycolytic capacity. However, three
fertile men also carried the G75C SNP. In these subjects, an
alternative enzyme or metabolic pathway might compensate for
the reduction in activity. One potential alternative is PGAM2,
which is expressed during the meiotic and postmeiotic stages of
spermatogenesis [27,28]. PGAM2 may be important for glycolytic
capacity. Another candidate is succinyl-CoA:3-oxoacid CoA
transferase, which is believed to act as a key enzyme in the
formation of ketone bodies by providing energy for sperm motility
[29,30]. A novel SNP in PGAM4 was identified in our case-control
study and was shown to cause impairment of PGAM activity in
vitro and in vivo. SNPs are abundant, being estimated to occur
once every 1,000 bases [31,32]. They sometimes have relevance
for specific diseases. SNP discoveries can provide useful disease
markers. Specifically, SNPs associated with male infertility are
likely to transmit the parental genome to subsequent generations
because of the progress of ARTs such as intracytoplasmic sperm
injection. We speculate that PGAM4 plays important roles other
than supporting sperm motility by supplying ATP because of its
presence in the acrosome. Thefunctionsoftheseglycolyticenzymes
are not known currently, although several other glycolytic enzymes
are present in the acrosome [20,25,33]. Glycolytic enzymes
including PGAM4 might be associated with the acrosome reaction,
which is essential for normal fertilization.
Testis-specific retrogenes were previously assumed to be
generated by retrotransposition to compensate for the meiotic
inactivation of an X-linked parental gene [7,34]. However, certain
important sex chromosome genes can restore or reactivate their
expression after meiotic division is complete [10,12], although
approximately 87% of X chromosome genes are repressed
postmeiotically [35]. Significant numbers of functional retrogenes
have been generated from autosomes in the X chromosome [36].
Most of such retrogenes are expressed specifically in the testis.
PGAM4 might have been recruited progressively throughout
primate evolution and could have attained the ability to escape
from MSCI, thereby enhancing the function of male spermato-
genic cells, although how these genes escape meiotic sex
chromosome inactivation remains poorly understood. Therefore,
the reduction in activity caused by a nonsynonymous SNP might
be associated with infertility.
In conclusion, we have demonstrated that the X-linked
retrogene PGAM4 is expressed both during postmeiotic stages of
spermatogenesis and in ejaculated spermatozoa. Moreover,
PGAM4 can escape from MSCI, while the G75C SNP causes
impaired enzymatic activity, leading to infertility in some men.
Materials and Methods
Participants
Japanese men with nonobstructive infertility (n=382) were
assigned to four subgroups according to World Health Organiza-
tion criteria for semen analysis [37]: nonobstructive azoospermia
(13%), severe oligozoospermia (semen density ,20 million cells/
mL; 31%), asthenozoospermia (density $20 million cells/mL and
motility ,33%) and no diagnosable abnormality (23%). No
patient had a history of medical conditions that could have caused
infertility, including but not limited to cryptorchidism, recurrent
infections, trauma, orchitis or varicocele. All subjects were
diagnosed with primary idiopathic infertility based on cytogenetic
analyses. The control group consisted of fertile men who had
fathered children born at a maternity clinic (n=251). All of the
donors were informed of the purpose of the study and gave written
permission for their blood and semen to be used for genomic DNA
analysis. This study was carried out with the approval of the
Institutional Review Board/Independent Ethics Committee of
Osaka University.
Preparation of Spermatozoa
Semen samples from fertile men were obtained and spermato-
zoa were purified from semen samples by two-layer percoll
gradient method using PureCeption kit (NAKA Medical Inc,
Tokyo, Japan).
Table 1. Prevalence of PGAM4 SNPs in infertile and proven-
fertile human populations.
Position
Geno
type Numver(%) of SNP
P
value
Nucleotide
Amino
acid infertile Proven fertile
75 Trp25 G/G 359 (95.5) 238 (98.3)
Trp25Cys C/C 17 (4.5) 3 (1.2) 0.025
138 Arg46 A/A 380 (99.7) 249 (100.0) 0.764
– C/C 1 (0.3) 0 (0)
539 Arg180 G/G 382 (99.7) 251 (100.0) 0.418
Arg180His A/A 1 (0.3) 0 (0)
Translation start site was +1.
doi:10.1371/journal.pone.0035195.t001
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Total RNA of human leukocytes, testes and spermatozoa was
extracted as the protocol of RNAqueous kit (Life Technologies
Japan, Tokyo, Japan). RT–PCR of samples from human
leukocytes, testes and spermatozoa, and PCR analysis of a human
testis-specific cDNA library [38] were performed using PrimeS-
TAR HS DNA Polymerase (TaKaRa Bio, Kyoto, Japan). Two
primer pairs were designed for the selective measurement of
PGAM4 expression by nested PCR. The sequences of the first
primer pair were 59–CAGAAGATCAGCTACCCTCCTA–39
and 59–ACATCACCATGCAGATTACATTCA–39. The se-
quences of the nested primer pair were 59–CTACCCTCCTAT-
GAGAGTCC–39 and 59–GGGCAGAGGGACAAGACCA–39.
These primers contained one, two, or three mismatches (bold
type).
Overexpression of PGAM1 and PGAM4
PGAM1 and PGAM4 fragments were amplified from a human
testis-specific cDNA library by PCR. The PGAM1 and PGAM4
primer pairs were designed to contain HindIII and BamHI sites.
The sequences of the PGAM1 first-round PCR primers were 59–
CCCAGCCCGCCGCCATGGC–39 and 59–GGGCAGAGG-
Figure 3. PGAM enzymatic activity assays in vitro and in vivo. (A) Lysates of cells overexpressing PGAM1 or PGAM4 were compared using
untransfected COS7 cells and cells transfected with empty pcDNA3.1+ as controls. (B) Lysates from cells overexpressing PGAM4 or PGAM4 Trp25Cys
(W25C) were compared with control lysates. Equal amounts of overexpressed PGAM4 and PGAM4 with the SNP were confirmed by immunoblotting
using anti-PGAM4 antibodies. (C) The supernatant and precipitated proteins that were separated from the fresh ejaculated spermatozoa of a fertile
man were examined to determine the hydrophilicity of the enzyme. (D) Frozen spermatozoa from infertile men with the Trp25Cys SNP and those
without the SNP. The seminal sperm densities for patients 1 to 3 were 39, 18 and 70 million/mL, respectively, and the motility levels were 35%, 30%
and 2%, respectively. The mean seminal sperm density of patients without the Trp25Cys SNP was 41 million/mL and the mean motility level was 60%.
**p,0.01. ***p,0.001. The experiments for PGAM1 and 4 in vitro enzymatic activity assays were performed independently 8 times. The PGAM
enzymatic activities of spermatozoa were measured 3 times repeatedly by each sample and the averaged value were defined as individual enzymatic
activity. Bars represent averages and standard deviations.
doi:10.1371/journal.pone.0035195.g003
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PCR primers were 59–CAGAAGATCAGCTACCCTCCTA–39
and 59–GGGCAGAGGGACAAGACCA–39. The amplified
DNA fragments produced by the first PCR were used for the
second round of PCR. The sequences of the primers used in the
second-round PCR were 59–GCGAAGCTTCGCCGC-
CATGGCCGCCTACAAACTGG–39 and 59–GCGGATC-
CACTTCTTGGCCTTGCCCTGGG–39. Following successful
amplification by PCR, the PGAM amplicons were subcloned into
the multicloning site of the plasmid vector pcDNA3.1+ (Invitro-
gen, Carlsbad, CA, USA). The plasmids were then separately
transfected into 2610
5 COS-7 cells using Lipofectamine 2000
(Invitrogen). After incubation for 48 h, the cells were harvested.
Preparation of a PGAM4-Specific Antibody
A peptide sequence (Ac-SYESPKDTI-X-Cys-NH2) corre-
sponding to amino acid residues 152–160 of PGAM4 was
designed to distinguish the PGAM4 protein from PGAM1 (the
differences from PGAM1 are highlighted in bold). Preparation of
the rabbit polyclonal antiserum and affinity column purification
were performed by the Peptide Institute of Osaka.
Immunoblotting
First, 8 mg of transfected cell protein extracts and 75 mg of tissue
protein were separated by SDS-PAGE and electroblotted onto
PVDF membranes. The primary antibodies were anti-PGAM1/4
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
diluted 1/1000, anti-PGAM1/4 antibody adsorbed with PGAM4
protein, and anti-PGAM4-specific antibody diluted 1/100. After
blocking with 4% BlockAce (DS Pharma Biomedical, Osaka,
Japan) in PBS-T, the membranes were reacted with primary
antibodies and secondary antibodies diluted 1/3000 at room
temperature for 1 hour. The antigen-antibody complexes were
detected using ECL Prime (GE Healthcare Japan, Tokyo, Japan).
Then, the membranes were stripped and reprobed.
Immunofluorescence
Bouin’s solution-fixed, paraffin-embedded human testis was cut
into 5-mm-thick sections and mounted on silane-coated slides.
Purified human spermatozoa were also mounted on the slide and
dried. These sections were boiled for 20 minutes in 0.01 M sodium
citrate to unmask the epitope and permeabilized with 0.2%
Triton-X in PBS-T for 10 minutes. After blocking with 10%
bovine serum albumin for 20 minutes, the sections were probed
with primary antibodies at 4uC overnight. The primary antibodies
used were anti-PGAM1/4 antibody, anti-PGAM1/4 antibody
adsorbed with PGAM4 protein, and anti-PGAM4-specific anti-
body diluted 1/100. The sections were reacted for 1 hour with the
secondary antibodies anti-goat IgG FITC-conjugated and anti-
rabbit IgG Rhodamine (Santa Cruz) diluted 1/400.’’
PGAM Enzymatic Activity Assay
PGAM enzymatic activity was measured using a coupled
enzyme assay procedure [19] with minor modifications. Under
standard conditions at 25uC, the change in absorbance at 240 nm
in Tris buffer (containing 10 mM 3-PGA, 10 U enolase and
5 mM MgSO4) was measured with a spectrophotometer. Enolase
converts 2-PGA, the product of the activity of the PGAM enzyme,
to phosphoenolpyruvate (PEP). Enzyme activity was calculated
based on the increase in absorbance after 60 min using a molar
extinction coefficient of 1,750 for PEP knowing that 1.5 mol of 2-
PGA yields 1 mol of PEP. Protein concentrations were determined
using a Lowry protein assay with bovine serum albumin as the
standard.
Statistical Analysis
Differences between the experimental and control conditions
were compared using Student t test. Significant differences
(P,0.05) are discussed here.
Supporting Information
Figure S1 Amino acid alignments for PGAM1 and
PGAM4. Putative amino acids of PGAM4 has 97.2% identity
with those of PGAM1. LxRHGExxxN motif for PGAM enzymatic
activity was showed in grey box.
(DOC)
Figure S2 Analysis of PGAM4 gene expression. (A)
Amplified products were analyzed by restriction enzyme digestion.
A BstXI restriction site is present in PGAM4, but not in PGAM1,
despite the high sequence identity between them (97.2%). The
380-bp amplification product was digested into two fragments (239
and 141 bp). (B) PCR using a human testis-specific cDNA library.
M, 100-bp ladder DNA marker; C, Control.
(TIF)
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